Radiopharm Theranostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	82	52	17	36	38	-
Market Cap Growth	45.53%	197.41%	-50.90%	-7.01%	-	-
Enterprise Value	45	14	16	13	6	-
Last Close Price	0.02	0.02	0.04	0.10	0.14	-
PS Ratio	5.01	4.16	8.93	5.74	-	-
PB Ratio	1.63	1.21	0.64	0.78	0.61	-
P/TBV Ratio	12.16	-	-	-	5.56	-
EV/Sales Ratio	2.77	1.15	8.02	2.04	-	-
Debt / Equity Ratio	-	-	-	-	-	-0.47
Net Debt / Equity Ratio	-0.69	-0.68	-0.68	-0.26	-0.43	-0.26
Net Debt / EBITDA Ratio	0.88	0.90	0.58	0.46	1.59	-
Net Debt / FCF Ratio	0.93	0.80	0.81	0.50	2.72	-0.40
Asset Turnover	0.18	0.16	0.03	0.08	-	-
Quick Ratio	3.00	2.65	1.11	1.22	3.43	0.21
Current Ratio	3.01	2.67	1.30	1.23	3.46	0.21
Return on Equity (ROE)	-92.10%	-109.20%	-131.49%	-63.78%	-96.82%	-
Return on Assets (ROA)	-28.33%	-27.70%	-30.04%	-22.57%	-29.86%	-
Return on Capital Employed (ROCE)	-54.80%	-49.10%	-64.90%	-46.30%	-26.40%	932.90%
Earnings Yield	-57.14%	-73.69%	-274.09%	-97.15%	-79.40%	-
FCF Yield	-	-70.43%	-131.34%	-65.25%	-25.86%	-
Buyback Yield / Dilution	-114.63%	-438.49%	-26.36%	-68.74%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.